8-K 1 v010531_8k.txt ================================================================================ SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ----------------- FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 ----------------- Date of Report (Date of earliest event reported): December 29, 2004 ----------------- NOVINT TECHNOLOGIES, INC. (Exact name of registrant as specified in Charter) DELAWARE 000-00000 85-0461778 (State or other jurisdiction of (Commission File No.) (IRS Employee incorporation or organization) Identification No.) 4109 Bryan Ave NW Albuquerque, New Mexico 87114 (Address of Principal Executive Offices) 866-298-4420 (Issuer Telephone Number) ================================================================================ Item 9.01 Financial Statements and Exhibits The Registrant hereby presents its unaudited but reviewed financial statements for the quarter ended September 30, 2004. Novint Technologies, Inc. BALANCE SHEETS
September 30, 2004 December 31, 2003 ------------------ ----------------- ASSETS (Unaudited) (Audited) CURRENT ASSETS: Cash and cash equivalents $ 1,536,843 $ 32,119 Restricted cash (Note 3) -- 291,254 Marketable equity securities, available for sale (Note 4) 497 497 Prepaid interest expense -- 24,750 Prepaid private placement issuance costs -- 293,753 Prepaid consortium dues 11,250 -- Accounts receivable 132,690 81,865 Inventory -- -- Costs and estimated earnings in excess of billings on contracts (Note 5) 51,909 37,060 ----------- ----------- Total current assets 1,733,189 761,298 ----------- ----------- SOFTWARE DEVELOPMENT COSTS, NET (Note 6) 4,002 16,012 ----------- ----------- PROPERTY AND EQUIPMENT: Office equipment 46,632 45,586 Software 7,246 7,246 Computer equipment 187,359 155,067 ----------- ----------- 241,237 207,899 Less: Accumulated depreciation 157,145 124,146 ----------- ----------- Total property and equipment 84,092 83,753 ----------- ----------- INTANGIBLE ASSETS, NET (Note 7) 43,234 111,313 ----------- ----------- Total assets $ 1,864,517 $ 972,376 =========== ===========
The accompanying notes are an integral part of these financial statements. 4 Novint Technologies, Inc. BALANCE SHEETS
September 30, 2004 December 31, 2003 ------------------ ----------------- (Unaudited) (Audited) LIABILITIES AND STOCKHOLDERS' EQUITY CURRENT LIABILITIES: Accounts payable $ 65,638 $ 13,891 Accrued payroll related liabilities 11,209 175,846 Accrued consulting fees -- 86,380 Other accrued liabilities 70,855 46,687 Billings in excess of costs and estimated earnings 51,510 -- Notes payable, investor (Note 8) -- 100,000 Notes payable, net of discount (Note 8) -- 378,017 ----------- ----------- Total current liabilities 199,212 800,821 ----------- ----------- COMMITMENTS AND CONTINGENCIES (Note 9) MANDATORILY REDEEMABLE, CONVERTIBLE PREFERRED STOCK Series A: aggregate liquidation preference, $100,000, $0.01 par value; authorized 400,000 shares, issued and outstanding 239,827 145,388 ----------- ----------- STOCKHOLDERS' EQUITY (Note 10): Common stock, authorized 50,000,000 shares, $0.01 par value; 13,735,814 and 10,028,026 issued as of June 30, 2004 and December 31, 2003, respectively; 13,535,814 and 10,028,026 outstanding as of June 30, 2004 and December 31, 2003, respectively 135,858 100,280 Additional paid-in capital 5,643,260 2,147,028 Accumulated deficit (3,582,535) (2,211,586) Accumulated other comprehensive loss (Note 4) (4,605) (4,605) Unearned compensation (766,500) (4,950) ----------- ----------- Total stockholders' equity 1,425,478 26,167 ----------- ----------- Total liabilities and stockholders' equity $ 1,864,517 $ 972,376 =========== ===========
The accompanying notes are an integral part of these financial statements. 5 Novint Technologies, Inc. STATEMENTS OF OPERATIONS (Unaudited)
Three Months Ended Nine Months Ended ---------------------------- ---------------------------- 9/30/2004 9/30/2003 9/30/2004 9/30/2003 ------------ ------------ ------------ ------------ Revenue Project $ 86,928 $ 94,131 $ 133,089 $ 234,454 Products 47,177 -- 91,172 143,678 ------------ ------------ ------------ ------------ Total revenue 134,105 94,131 224,261 378,132 Cost of goods sold 72,526 87,601 155,824 255,327 ------------ ------------ ------------ ------------ Gross margin 61,579 6,530 68,437 122,805 ------------ ------------ ------------ ------------ Costs and expenses Research and development 57,109 2,713 137,657 9,338 General and administrative 346,864 156,589 813,036 296,049 Depreciation and amortization 17,954 67,508 135,133 202,562 Sales and marketing 31,712 3,688 68,466 6,888 ------------ ------------ ------------ ------------ Total costs and expenses 453,639 230,498 1,154,292 514,837 ------------ ------------ ------------ ------------ Loss from operations (392,060) (223,968) (1,085,855) (392,032) ------------ ------------ ------------ ------------ Other expense Realized loss on disposition of securities -- -- -- 239,040 Interest expense 1,599 1,875 190,655 3,750 ------------ ------------ ------------ ------------ Total other expenses 1,599 1,875 190,655 242,790 ------------ ------------ ------------ ------------ Loss before income taxes (393,659) (225,843) (1,276,510) (634,822) Income tax expense -- -- -- -- ------------ ------------ ------------ ------------ Net loss (393,659) (225,843) (1,276,510) (634,822) Other comprehensive loss, net of tax Change in unrealized loss on securities -- -- -- (10,416) ------------ ------------ ------------ ------------ Comprehensive loss (393,659) (225,843) (1,276,510) (645,238) Preferred stock accretion (6,699) (3,948) (94,439) (11,516) ------------ ------------ ------------ ------------ Net loss available to common stockholders $ (400,358) $ (229,791) $ (1,370,949) $ (656,754) ============ ============ ============ ============ Loss per share, basic and diluted: Net loss $ (0.03) $ (0.02) $ (0.10) $ (0.07) ============ ============ ============ ============ Net loss available to common stockholders $ (0.03) $ (0.02) $ (0.11) $ (0.07) ============ ============ ============ ============ Weighted-average common shares outstanding, basic and diluted 13,216,147 9,274,020 12,747,270 9,295,140 ============ ============ ============ ============
The accompanying notes are an integral part of these financial statements. 6 Novint Technologies, Inc. STATEMENTS OF STOCKHOLDERS' EQUITY Year Ended December 31, 2003 and Nine Months Ended September 30, 2004
Mandatorily Redeemable, Convertible Preferred Stock Common Stock Additional ------------------------- ------------------------- Paid-in Shares Amount Shares Amount Capital ----------- ----------- ----------- ----------- ----------- Balances, as restated, December 31, 2002 4,000 $ 129,811 9,244,834 $ 92,448 $ 1,380,703 Common stock issued to consultants for services -- -- 209,092 2,091 135,909 Common stock issued for Board of Directors services -- -- 30,304 303 19,697 Common stock issued for cash -- -- 378,788 3,788 246,212 Common stock issued for interest -- -- 50,000 500 32,500 Common stock issued upon exercise of options for cash -- -- 115,008 1,150 -- Options issued to consultants for services -- -- -- -- 55,776 Warrants issued in private placement transaction -- -- -- -- 85,007 Warrants issued in connection with notes payable -- -- -- -- 182,974 Executive compensation paid by shareholder -- -- -- -- 8,250 Amortization of unearned compensation -- -- -- -- -- Change in unrealized holding loss on investments -- -- -- -- -- Reclassification of realized loss on investments -- -- -- -- -- Preferred stock accretion -- 15,577 -- -- -- Net loss -- -- -- -- -- ----------- ----------- ----------- ----------- ----------- Balances, December 31, 2003 4,000 $ 145,388 10,028,026 $ 100,280 $ 2,147,028 =========== =========== =========== =========== =========== Common stock issued to consultants for services -- -- 110,000 1,100 108,900 Common stock issued for cash -- -- 378,788 3,788 246,212 Common stock and warrants issued in private placement transaction, net of issuance costs -- -- 3,049,000 30,490 2,059,173 Options issued to employees for future services -- -- -- -- 806,500 Options issued to consultants for future services -- -- -- -- 26,735 Options issued to consultants for services -- -- -- -- 23,225 Cancelled options for employees -- -- -- -- (40,000) Common stock issued upon exercise of options for services -- -- 20,000 200 -- Amortization of unearned compensation -- -- -- -- -- Modification of warrants issued in private placement transaction -- -- -- -- 265,488 Preferred stock accretion -- 94,439 -- -- -- Net loss -- -- -- -- -- ----------- ----------- ----------- ----------- ----------- Balances, September 30, 2004 4,000 $ 239,827 13,585,814 $ 135,858 $ 5,643,260 =========== =========== =========== =========== =========== Accumulated Retained Other Earnings Comprehensive Unearned (Deficit) Loss Compensation Total ----------- ----------- ----------- ----------- Balances, as restated, December 31, 2002 $(1,205,459) $ (233,229) $ (10,300) $ 24,163 Common stock issued to consultants for services -- -- -- 138,000 Common stock issued for Board of Directors services -- -- -- 20,000 Common stock issued for cash -- -- -- 250,000 Common stock issued for interest -- -- -- 33,000 Common stock issued upon exercise of options for cash -- -- -- 1,150 Options issued to consultants for services -- -- -- 55,776 Warrants issued in private placement transaction -- -- -- 85,007 Warrants issued in connection with notes payable -- -- -- 182,974 Executive compensation paid by shareholder -- -- -- 8,250 Amortization of unearned compensation -- -- 5,350 5,350 Change in unrealized holding loss on investments -- (10,416) -- (10,416) Reclassification of realized loss on investments -- 239,040 -- 239,040 Preferred stock accretion (15,577) -- -- (15,577) Net loss (990,550) -- -- (990,550) ----------- ----------- ----------- ----------- Balances, December 31, 2003 $(2,211,586) $ (4,605) $ (4,950) $ 26,167 =========== =========== =========== =========== Common stock issued to consultants for services -- -- -- 110,000 Common stock issued for cash -- -- -- 250,000 Common stock and warrants issued in private placement transaction, net of issuance costs -- -- -- 2,089,663 Options issued to employees for future services -- -- (806,500) -- Options issued to consultants for future services -- -- -- 26,735 Options issued to consultants for services -- -- -- 23,225 Cancelled options for employees -- -- 40,000 -- Common stock issued upon exercise of options for services -- -- -- 200 Amortization of unearned compensation -- -- 4,950 4,950 Modification of warrants issued in private placement transaction -- -- -- 265,488 Preferred stock accretion (94,439) -- -- (94,439) Net loss (1,276,510) -- -- (1,276,510) ----------- ----------- ----------- ----------- Balances, September 30, 2004 $(3,582,535) $ (4,605) $ (766,500) $ 1,425,478 =========== =========== =========== ===========
The accompanying notes are an integral part of these financial statements. 7 Novint Technologies, Inc. STATEMENT OF CASH FLOWS (Unaudited)
Nine Months Ended -------------------------- 9/30/2004 9/30/2003 ----------- ----------- Cash flows from operating activities: Net loss $(1,276,510) $ (634,822) Adjustments to reconcile net loss to net cash used in operating activities Depreciation and amortization 135,133 202,562 Common stock issued for services 110,000 44,500 Options issued to employees for services -- 49,581 Options issued to consultants for services 49,960 85,007 Options exercised for services performed 200 -- Discount on notes payable charged to interest expense 121,983 5,350 Reserve for conract loss -- 18,413 Amortization of unearned compensation 4,950 -- Services paid with investments -- 16,600 Realized loss on disposition of securities -- 239,040 Changes in operating assets and liabilities: -- Accounts receivable (50,825) (74,817) Prepaid expenses 307,253 (79,382) Accounts payable 51,747 (6,506) Accrued liabilities (226,850) 73,953 Inventory -- -- Costs and estimated earnings in excess of billings on contracts, net (14,849) 38,729 Billings in excess of costs and estimated earnings on contracts, net 51,510 4,672 ----------- ----------- Net cash used by operating activities (736,298) (17,120) ----------- ----------- Cash flows from investing activities: Capital expenditures (55,383) Lapse of restrictions on cash 291,254 (1,795) ----------- ----------- Net cash provided (used) by investing activities 235,871 (1,795) ----------- ----------- Cash flows from financing activities: Proceeds from issuance of common stock 2,605,151 51,150 Repayment of notes payable, investor (100,000) -- Repayment of notes payable (500,000) -- ----------- ----------- Net cash provided by financing activities 2,005,151 51,150 ----------- ----------- Net decrease in cash and cash equivalents 1,504,724 32,235 Cash and cash equivalents at beginning of period 32,119 4,820 ----------- ----------- Cash and cash equivalents at end of period $ 1,536,843 $ 37,055 =========== =========== Supplemental information: Interest paid $ 61,600 $ -- =========== =========== Services paid with investments $ -- $ 16,600 =========== =========== Fair value accretion on manditorily redeemable, convertible preferred stock $ 94,439 $ 7,568 =========== =========== Modification of warrants issued in private placement transaction $ 265,488 $ -- =========== ===========
The accompanying notes are an integral part of these financial statements. 8 Novint Technologies, Inc. NOTES TO FINANCIAL STATEMENTS (continued) September 30, 2004 (unaudited) NOTE 1 - PRESENTATION OF UNAUDITED FINANCIAL STATEMENTS The accompanying interim financial data is unaudited, however in the opinion of management, the interim data includes all adjustments, consisting of normal recurring adjustments, necessary for a fair statement of the results for the interim period. The financial statements included herein have been prepared by Novint in accordance with the rules and regulations of the Securities and Exchange Commission. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to such rules and regulations, although Novint believes that the disclosures included herein are adequate to make the information presented not misleading. The organization and business of Novint, accounting policies followed by Novint and other information are contained in the notes to Novint's financial statements filed as part of the Company's audited financial statements for the year ended December 31, 2003 included in this registration statement. These unaudited quarterly statements should be read in conjunction with the financial statements as of and for the years ended December 31, 2003 and 2002 included in this Registration Statement. In the opinion of management, the accompanying interim financial statements reflect all adjustments necessary for the fair presentation of the financial position, results of operations, and cash flows for the interim periods presented. Adjustments, if any, are reflected in the current quarter balances. The results of operations for interim periods are not necessarily indicative of results which may be expected for any other interim period or for the year ending December 31, 2004. NOTE 2 - CAPITAL RESOURCES Since inception, Novint has incurred net operating losses and other equity charges which have resulted in an accumulated deficit of $3,582,535 at September 30, 2004 and operations using net cash of $736,298 during the first nine months of 2004. Management has raised equity totaling approximately $5.7 million through various private equity transactions. Management believes the proceeds from these private placements, along with revenues from project and product sales, will allow Novint to satisfy its short and long-term obligations and provide enough cash flow for Novint to continue operations through September 30, 2005. The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America, which contemplate continuation of Novint as a going concern. Should Novint be unable to raise additional capital or ramp up product sales, additional adjustments may be required. In May 2004, Novint completed a private placement raising gross proceeds of $909,000 in exchange for 909,000 shares of common stock at an exercise price of $1.00 per share and warrants to purchase 454,500 shares of common stock with an exercise price of $2.00 per share. After cash fees incurred in connection with this placement, net cash proceeds to Novint were $850,270. In February 2004, Novint completed a private placement raising gross proceeds of $2,140,000 in exchange for 2,140,000 shares of common stock at an exercise price of $1.00 per share and warrants to purchase 1,070,000 shares of common stock with an exercise price of $2.00 per share. After cash fees incurred in connection with this placement, net cash proceeds to Novint were $1,505,393. On January 31, 2004, Novint entered into a stock purchase agreement with a private investor. In connection with this agreement, Novint issued 378,788 shares of its common stock for $0.66 per share and received gross proceeds of $250,000. Novint issued 300,000 warrants to their attorney for services rendered in connection with the private placement. Such costs, totaling approximately $266,000 for the nine months ended September 30, 2004, have been netted against the proceeds from the private placement in the accompanying statement of stockholders' equity. See Note 11. 9 Novint Technologies, Inc. NOTES TO UNAUDITED FINANCIAL STATEMENTS September 30, 2004 NOTE 3 - SUMMARY OF CHANGES IN SIGNIFICANT ACCOUNTING POLICIES Restricted Cash In connection with Novint's private placement, a loan of $500,000 was provided in November 2003 for use solely with private placement expenses and a hardware licensing agreement with a third party. As of December 31, 2003, Novint had approximately $291,000 in cash on hand restricted for use to close the private placement and payment of milestones pursuant to the licensing agreement. As of September 30, 2004, the $500,000 loan was repaid and the restriction on the cash was lifted. Accounts Receivable/Concentration of Credit Risk Novint utilizes the allowance method for accounts receivable valuation, providing for allowances for estimated uncollectible accounts receivable. At September 30, 2004 and December 31, 2003, management believes all receivables are collectible; therefore, no allowances have been provided. Novint's financial instruments that are exposed to concentration of credit risk consist primarily of uninsured cash, cash equivalents and available-for- sale securities held at commercial banks and institutions primarily in the United States and trade receivables from Novint's customers. For the nine months ended September 30, 2004, Novint had sales to four customers that accounted for approximately 36%, 22%, 21%, and 13% of its sales. For the nine months ended September 30, 2003, Novint had sales to three customers that accounted for approximately 39%, 35% and 10% of its sales. Novint routinely assesses the financial strength of its customers as part of its consideration of accounts receivable collectibility by performing credit evaluations of customers. Trade receivables are not collateralized. Novint generally grants credit terms to most customers ranging from 30 to 90 days. For the nine months ended September 30, 2004 and 2003, Novint's revenues were substantially earned from a government agency headquartered in New Mexico and several government contractors located in the United States. As of September 30, 2004 and 2003, Novint's trade receivables were substantially due from several prominent government contractors located in the United States. Inventory Novint values its material inventory at the lower of cost or market. Cost is determined on the first-in, first-out ("FIFO") method. Novint evaluates the need to record adjustments for impairment of inventory on a periodic basis and any required adjustment is made to record inventory at its estimated net realizable value. Novint had no inventory at September 30, 2004 or December 31, 2003. Intangible Assets Intangible assets, which consist of licensing agreements and a patent, are carried at cost less accumulated amortization. Amortization is computed using the straight-line method over the economic life of the asset, or useful life of the license agreements, which are 3 and 12 years. For the 9 months ended September 30, 2004 and the year ended December 31, 2003, Novint recognized amortization expense of approximately $90,000 and $221,000, respectively, related to the intangible assets. 10 Novint Technologies, Inc. NOTES TO UNAUDITED FINANCIAL STATEMENTS September 30, 2004 Impairment of Long-Lived Assets and Long-Lived Assets to be Disposed Of Novint reviews its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. Assets to be disposed of are reported at the lower of the carrying amount or fair value less costs to sell. No impairment loss was recorded in 2004 or 2003. Loss per Common Share The Financial Accounting Standards Board (FASB) issued SFAS 128, Earnings Per Share, which is effective for periods ending after December 15, 1997. SFAS 128 provides for the calculation of "Basic" and "Diluted" earnings per share. Basic earnings per share includes no dilution and is computed by dividing loss to common shareholders by the weighted average number of common shares outstanding for the period. All potentially dilutive securities have been excluded from the computations since they would be antidilutive. However, these dilutive securities could potentially dilute earnings per share in the future. As of September 30, 2004 and 2003, Novint had a total of 9,201,338 and 5,515,565 potentially dilutive securities, respectively. Stock Option Plans Novint applies the intrinsic value-based method of accounting prescribed by Accounting Principles Board (APB) Opinion No. 25, Accounting for Stock Issued to Employees, and related interpretations, in accounting for the recognition and measurement of its fixed plan stock options. As such, unearned compensation is recorded on the date of grant if the current market price of the underlying stock exceeds the exercise price, and is amortized over the service period. As of September 30, 2004 and December 31, 2003, amortization of unearned compensation approximates $5,000 and $5,000, respectively. SFAS 123, Accounting for Stock-Based Compensation, established accounting and disclosure requirements using a fair value-based method of accounting for stock-based employee compensation plans. As permitted by SFAS 123, Novint has elected to continue to apply the intrinsic value-based method of accounting described above, and has adopted the disclosure-only requirements of SFAS l23. The following table illustrates the effect on net loss to common stockholders if Novint had applied the fair value recognition provisions of SFAS 123 to all stock-based employee compensation for the nine month period ended September 30. EPS has been calculated after the accretion of the preferred stock: 11 Novint Technologies, Inc. NOTES TO UNAUDITED FINANCIAL STATEMENTS September 30, 2004 September 30, September 30, 2004 2003 (unaudited) (unaudited) ----------- ----------- Net loss, as reported $(1,276,510) $ (634,822) Add: Stock-based employee compensation expense included in reported net income 4,950 5,350 Deduct: Total stock based employee compensation expense determined under fair value based method for all awards (18,018) (154,602) ----------- ----------- Pro forma net loss $(1,289,578) $ (784,074) =========== =========== Loss per share, basic and diluted: As reported $ (0.10) $ (0.07) Pro forma $ (0.10) $ (0.08) In calculating the fair value of options for the above pro forma disclosure, the following assumptions were used for the quarter ended September 30, 2004: a risk free rate of 3.27%, volatility of Novint's stock of 100%, estimated lives of the options of 3 years, an exercise price of $0.66 per share, and a fair market value of $1.00 per share. Reclassifications Certain reclassifications have been made to prior year or quarter balances in order to conform to the current year or quarter presentation. NOTE 4 - MARKETABLE EQUITY SECURITIES In September 2000, Novint entered into a Research and Development contract to provide to Manhattan Scientifics, Inc. (Manhattan), a publicly-traded company located in New York, a license and rights to sublicense haptics technology. Coincident with the contract agreement, Novint and Manhattan entered into an exchange transaction that was finalized in May 2001, whose terms provided that Manhattan would receive 4,067,200 shares of Novint's stock, and Novint would receive 1,000,000 shares of Manhattan stock. In addition, Novint obtained from Manhattan exclusive ownership of the worldwide IP rights and associated obligations of Teneo, a privately owned company previously acquired by Manhattan. The rights in Teneo are recorded on the accompanying September 30, 2004 and December 31, 2003 balance sheets as licensing agreements (see Note 7). At September 30, 2004 and December 31, 2003, Novint held 8,284 shares of the original 1,000,000 shares of Manhattan common stock acquired in the exchange transaction, with original cost basis of $5,102. At September 30, 2004 and December 31, 2003, there were unrealized holding losses of $4,605 related to its investment in marketable equity securities, which have been presented as accumulated other comprehensive losses in the statement of stockholders' equity. NOTE 5 - COSTS AND ESTIMATED EARNINGS IN EXCESS OF BILLINGS ON CONTRACTS Costs and estimated earnings in excess of billings on contracts consist of the following at:
September 30, December 31, 2004 2003 (Unaudited) (Audited) ------------ ------------ Costs and estimated earnings on uncompleted contracts $ 51,909 $ 67,000 Billings on uncompleted contracts -- (29,940) ------------ ------------ Costs and estimated earnings in excess of billings on uncompleted contracts $ 51,909 $ 37,060 ============ ============
Billings in excess of costs and estimated earnings on contracts consist of the following at December 31:
September 30, December 31, 2004 2003 (Unaudited) (Audited) ------------ ------------ Billings on uncompleted contracts $ 132,690 $ -- Costs and estimated earnings on uncompleted contracts 81,180 -- ------------ ------------ Billings in excess of costs and estimated earnings on uncompleted contracts $ 51,510 $ -- ============ ============
12 Novint Technologies, Inc. NOTES TO UNAUDITED FINANCIAL STATEMENTS September 30, 2004 NOTE 6 - SOFTWARE DEVELOPMENT COSTS Capitalized software development costs consisted of the following at:
September 30, December 31, 2004 2003 (Unaudited) (Audited) ------------ ------------ Software development costs $ 80,058 $ 80,058 Less accumulated amortization 76,056 64,046 ------------ ------------ $ 4,002 $ 16,012 ============ ============
NOTE 7 - INTANGIBLE ASSETS Intangible assets consisted of the following at:
September 30, December 31, 2004 2003 (Unaudited) (Audited) ------------ ------------ Licensing agreement $ 680,000 $ 665,000 Patent 10,734 3,688 Less accumulated amortization (647,500) (557,375) ------------ ------------ $ 43,234 $ 111,313 ============ ============
NOTE 8 - NOTES PAYABLE In October 2002, Novint issued a promissory note of $100,000 with a maturity date of October 2003. During 2003, the maturity date was extended to October 2004. Novint repaid the $100,000 note in full in March 2004. In conjunction with the issuance of the $100,000 promissory note in October 2002, Novint issued 150,000 shares of common stock at a fair value of $0.05 per share in lieu of interest. Novint determined the fair value of their common stock to be $0.05 per share as determined by its Board of Directors based on the value of other instruments issued, such as preferred stock, during the prior year. In October 2003, as a result of the repayment extension and in accordance with the original terms of the promissory note, Novint issued an additional 50,000 shares of common stock at a fair value of $0.66 per share. Novint determined the fair value of their common stock to be $0.66 per share as a result of a third party common stock sale. The fair market value of the shares issued in lieu of interest has been recorded as interest expense over the term of the note. The fair value of the shares issued in 2003 total $33,000. During the year ended December 31, 2003, Novint recorded $8,250 on shares issued in 2003 as interest expense, and $24,750 was prepaid interest expense. The remaining fair value of $24,750 was properly recognized as interest expense during the 9 months ended September 30, 2004 upon repayment of the note. In November 2003, Novint issued a promissory note, which is secured by all of Novint's assets, of $500,000 with an interest rate of 12% per annum, maturity date of May 2004. During the 9 months ended September 30, 2004, Novint fully repaid this note, along with $60,000 of interest. In conjunction with the issuance of the $500,000 promissory note, Novint issued a warrant for the purchase of 500,000 shares of Novint's common stock at an exercise price of $0.50 per share. The warrant expires in November 2013. Novint calculated the relative fair value of the warrant to be approximately $183,000 using the Black-Scholes model based on the following assumptions: a risk-free rate of 4.31%, volatility of 86%, contractual life of 10 years, and a common stock fair market value of $0.66 per share. As these warrants were issued in connection with a note, the value of the warrant was recorded as a debt discount. At December 31, 2003, the unamortized discount totaled $122,000. This amount was charged to interest expense during the nine months ended September 30, 2004. 13 Novint Technologies, Inc. NOTES TO UNAUDITED FINANCIAL STATEMENTS September 30, 2004 NOTE 9 - INCOME TAXES Deferred income taxes reflect the tax consequences on future years for differences between the tax basis of assets and liabilities and their basis for financial reporting purposes. Temporary differences giving rise to the current deferred tax asset are the accrual for billings in excess of costs and estimated earnings and accounts payable, which are recorded for financial reporting purposes but not currently deductible for tax reporting. Temporary differences giving rise to the non-current deferred tax asset include accrued payroll not paid and contribution carryover, which are deductible for financial reporting purposes but not currently deductible for tax reporting. The other major temporary timing differences giving rise to the non-current deferred tax asset is the net operating loss carryforward. The temporary differences giving rise to the current deferred tax liability consist of accounts receivable, prepaid expenses and costs and estimated earnings in excess of billings that are accrued for financial reporting purposes but are not currently includible for tax reporting purposes. The temporary differences giving rise to the non-current deferred tax liability consist of the software costs that have been capitalized for financial reporting purposes but are deductible for tax reporting purposes. As a result of the significant net losses incurred during 2004 and in prior years and potential statutory limitations on the ability to recognize these losses, Novint recorded a valuation allowance to fully reserve its net deferred tax asset. NOTE 10 - COMMITMENTS AND CONTINGENCIES Novint has a month-to-month operating lease of $800 per month for office space. The monthly rent shall be paid in either cash or Manhattan Scientifics ("Manhattan") common stock in an amount of shares calculated based on the closing price of Manhattan stock on the previous trading day. Novint has no further relationship with the lessor beyond the lease agreement. Novint has a licensing agreement with Sandia National Laboratories (Sandia), which initially developed Flight, the precursor to e-TouchTM (the technology), and employed Novint's founder. The licensing agreement provides Novint the right to utilize the technology exclusively for a period of 12 years and non-exclusively in perpetuity and places certain restrictions on its use as well as requires Novint to pay 1.5 percent royalty fees to Sandia in connection with any income earned based upon the technology. Additionally, Novint is obligated to pay to Sandia on a semi-annual basis annual minimum earned royalties of $6,000 in 2001, $14,000 in 2002, $24,000 in 2003, and $30,000 from 2004 through 2011. The agreement also allows for sub-licensure of the technology to others, which was provided to Manhattan under an agreement dated September 24, 2000. As of September 30, 2004 and December 31, 2003, Novint had accrued approximately $22,500 and $24,000, respectively, in royalty fees owed to Sandia under the royalty agreement. Amounts owed to Sandia as of December 31, 2003 were paid in full during 2004. From time to time, in the normal course of business, Novint is subject to routine litigation incidental to their business. Although there can be no assurances as to the ultimate disposition of any such matters, it is the opinion of management, based upon the information available at this time, that there are no matters, individually or in the aggregate, that will have a material adverse effect on the results of operations and financial condition of Novint. In September 2004, Novint signed an agreement with Lunar Design, a product design firm, to design and develop their Haptics game controller. The work is estimated to take up to 9 months. Estimated costs will range between approximately $542,000 and $634,000, which will be billed on a time and materials basis. Lunar Design has agreed to accept payment in the form of cash, promissory note, or Novint common stock. As of September 30, 2004, no amounts have been paid to Lunar Design. 14 Novint Technologies, Inc. NOTES TO UNAUDITED FINANCIAL STATEMENTS September 30, 2004 NOTE 11 - STOCKHOLDERS' EQUITY Mandatorily Redeemable, Convertible Preferred Stock Novint is authorized to issue a maximum of 4,000 shares of preferred stock with $0.01 par value. On April 20, 2000, in connection with the license agreement with Sandia, Novint issued 4,000 shares of Series A mandatorily redeemable, convertible preferred stock at $0.25 per share. The preferred stock is convertible into fully paid and nonassessable common stock as follows: at the holder's option based on the conversion price in effect on the conversion date, or automatically upon the closing of an initial public offering which would result in 447,300 shares of common stock. The conversion price is to be (i) the subscription price ($100,000 when expressed as an aggregate amount, or $0.25 per share when expressed on a per share basis) divided by (ii) the conversion price in effect on the conversion date. Additionally, Novint is obligated to redeem the preferred shares, if there is no public offering (initial public offering or "IPO") or initial sale within 10 years from the issue date. If there is no IPO, Novint shall repurchase the number of shares of preferred stock as the holders thereof may from time to time request, but in any 12 month period, not more than 10% of the largest number of shares of preferred stock that have ever been outstanding, at an amount per share equal to the redemption price. The redemption price is the greater of (a) the subscription price, and (b) that portion of the fair market value of Novint, as determined in good faith by the Board of Directors, corresponding to the number of shares of common stock to which the shares of preferred stock to be redeemed would convert according to the conversion provisions. Accordingly, Novint has accreted the fair value of the common stock conversion to retained earnings over the 10 year life of the preferred stock. If an IPO occurs, Novint will recognize an additional charge to retained earnings of the converted shares at the fair value as compared to the IPO price. At September 30, 2004, the unaccreted fair value of the preferred stock totaled $239,827 based on the fair value of the stock at September 30, 2004 of $1.00 per share. Upon conversion, the preferred stock will be reclassified to common stock outstanding. The holders of the issued and outstanding shares of preferred stock shall have no voting rights. In all respects regarding dividends or distributions of any kind to holders of common stock, holders of preferred stock shall have the rights, privileges, and share in all respects as if such holders had converted the preferred stock to the number of shares of common stock corresponding to their conversion provisions. In the event of any voluntary or involuntary liquidation, dissolution or other winding up of Novint, the holders of the preferred stock shall be entitled to be paid the subscription price of all outstanding shares of preferred stock, in cash or in property taken at its fair value as determined by the Board of Directors, or both, at the election of the Board of Directors, prior to any distribution to the holders of common stock. Common Stock Novint is authorized to issue a maximum of 50,000,000 shares of common stock with a par value of $0.01 per share. For the period ended September 30, 2004 and the year ended December 31, 2003, Novint had 13,735,814 and 10,028,026 shares outstanding, respectively, and 13,535,814 and 10,028,025 shares issued, respectively. Private Placement A private placement offering was completed in February 2004 for $2,140,000. In connection with this offering, Novint issued 2,140,000 shares of common stock at an exercise price of $1.00 per share and warrants to purchase 1,070,000 shares of common stock at an exercise price of $2.00 per share. Novint received net cash proceeds of $1,505,393 (after fees were paid to their placement agent and lawyers). A second closing of the private placement offering was completed in May 2004 for $909,000. In connection with this offering, Novint issued 909,000 shares of common stock at an exercise price of $1.00 per share and warrants to purchase 454,500 shares of common stock at an exercise price of $2.00 per share. Novint received net cash proceeds of $850,440 (after fees were paid to their placement agent and lawyers). 15 Novint Technologies, Inc. NOTES TO UNAUDITED FINANCIAL STATEMENTS September 30, 2004 Equity Transactions On January 31, 2004, Novint entered into a stock purchase agreement with a private investor. In connection with this agreement, Novint issued 378,788 shares of its common stock at $0.66 per share and received gross proceeds of $250,000. The share price was based on a prior agreement with this investor. On February 25, 2004, Novint issued 10,000 shares of common stock at $1.00 per share to a consultant for services performed. Novint recognized $10,000 in consulting expense related to this issuance. On April 1, 2004, Novint committed to issue 250,000 shares of common stock at $1.00 per share to a consultant for future services. Vesting terms are as follows: 50,000 shares per quarter as long as the consultant is still providing services to Novint, up to a total of 250,000 shares, beginning April 1, 2004, Novint recognized $100,000 in consulting expense related to this issuance as of September 30, 2004. On April 8, 2004, Novint issued 20,000 shares of its common stock in connection with option exercises at $0.01 per share. On July 7, 2004, Novint committed to issue 10,000 shares of common stock at $1.00 per share to an employee for future services. Stock vests on July 7, 2005, and as such Novint had not recognized any expense related to this issuance as of September 30, 2004. Options and Warrants On February 18, 2004, Novint granted 1,205,000 options at an exercise price of $0.50 per share, with a 5-year annual vesting provision, to purchase common stock to various employees. These options had intrinsic value because the exercise price of $0.50 per share was less than the fair market value of $1.00 per share. Unearned compensation of $602,500 was recorded at the measurement date and will be amortized over the vesting period. On February 18, 2004, Novint granted to a consultant for future services 125,000 options to purchase common stock at an exercise price of $0.50 per share. The options have a 5-year annual vesting provision. Novint calculated the value of the options using the Black-Scholes model based on the following assumptions: a risk-free rate of 4.05%, volatility of 91%, estimated life of 10 years, and a fair market value of $1.00 per share. On June 10, 2004, Novint granted to various consultants for future services 300,000 options to purchase common stock at an exercise price of $0.66 per share. The options have a 5-year annual vesting provision. Novint calculated the value of these options using the Black-Scholes model based on the following assumptions: a risk-free rate of 4.81%, volatility of 100%, estimated life of 10 years, and a fair market value of $1.00 per share. The vesting schedules are prorated over the reporting period, and approximately $53,000 was recorded as consultant expense during the 9 months ended September 30, 2004. On June 10, 2004, Novint granted 500,000 options at an exercise price of $0.66 per share, with a 5-year annual vesting provision, to purchase common stock to an employee. These options had intrinsic value because the exercise price of $0.66 per share was less than the fair market value of $1.00 per share. Unearned compensation of $170,000 was recorded at the measurement date and will be amortized over the vesting period. On July 20, 2004, Novint granted 50,000 options at an exercise price of $0.66 per share, with a 5-year annual vesting provision, to purchase common stock to an employee. These options had intrinsic value because the exercise price of $0.66 per share was less than the fair market value of $1.00 per share. Unearned compensation of $17,000 was recorded at the measurement date and will be amortized over the vesting period. On August 9, 2004, Novint granted 50,000 options at an exercise price of $0.66 per share, with a 5-year annual vesting provision, to purchase common stock to an employee. These options had intrinsic value because the exercise price of $0.66 per share was less than the fair market value of $1.00 per share. Unearned compensation of $17,000 was recorded at the measurement date and will be amortized over the vesting period. On August 9, 2004, Novint cancelled 80,000 options previously granted at an exercise price of $0.50 per share, with a 5-year annual vesting provision, to purchase common stock to an employee. These options had intrinsic value because the exercise price of $0.66 per share was less than the fair market value of $1.00 per share. Unearned compensation of $40,000 had been recorded at the measurement date and was reversed at September 30, 2004. 16 Novint Technologies, Inc. NOTES TO UNAUDITED FINANCIAL STATEMENTS September 30, 2004 On June 10, 2004, Novint granted to a former Board of Director providing consulting services for services 25,000 options to purchase common stock at an exercise price of $0.66 per share. These options immediately vest. Novint calculated the value of these options using the Black-Scholes model based on the following assumptions: a risk-free rate of 4.81%, volatility of 100%, estimated life of 10 years, and a fair market value of $1.00 per share. Approximately $23,000 was recorded as consultant expense during the 9 months ended September 30, 2004. Warrants In September 2003, Novint issued 300,000 warrants to an attorney for services rendered in connection with a private placement at an exercise price of $0.66 per share. These warrants vested 50% upon issuance in September 2003, and 50% on the 1st anniversary date (September 2004) of the execution date of this warrant provided that the holder continued to represent the company as its legal counsel on such vesting date. In March 2004, Novint amended the exercise price from $0.66 per share to $0.50 per share to compensate them fairly for their services. As the terms of the original Warrant agreement do not specifically address how such modifications should be treated, Novint has recorded an additional approximately $105,000, which represents the difference in the fair value of this modification. The following assumptions were used for the quarter ended March 31, 2004 in calculating the fair value difference of this warrant modification under the Black-Scholes model: risk free rate of 3.75%, volatility of 91%, contractual term of 10 years, exercise price of $0.50 per share, and fair market value of $1.00 per share. Novint recognized the remaining 50% value of the warrant during the quarter ended September 30, 2004. The following assumptions were used for the quarter ended September 30, 2004 in calculating the fair value of this warrant under the Black-Scholes model: risk free rate of 4.14%, volatility of 79%, contractual term of 10 years, exercise price of $0.50 per share, and fair market value of $1.00 per share. A total amount of approximately $266,000 has been recorded to reflect the fair value of these warrants, which have been recorded as a reduction of the offering proceeds in the statement of stockholders' equity. In March 2004, Novint issued 200,000 warrants to a consulting group for services rendered in connection with a private placement at an exercise price of $1.00 per share. The warrants vested immediately, and have a life of 5 years. The fair market value of the warrants totaled approximately $142,000. Novint calculated the warrant expense using the Black-Scholes model based on the following assumptions: a risk-free rate of 2.39%, volatility of 91%, estimated life of 5 years, and a fair market value of $1.00 per share. As of September 30, 2004, Novint recognized this amount as a reduction of the offering proceeds. In April 2004, Novint issued 263,500 warrants to a consulting group for services rendered in connection with a private placement at an exercise price of $1.00 per share. The warrants vested immediately, and have a life of 5 years. The fair market value of the warrants totaled approximately $200,000. Novint calculated the warrant expense using the Black-Scholes model based on the following assumptions: a risk-free rate of 3.49%, volatility of 100%, estimated life of 5 years, and a fair market value of $1.00 per share. As of September 30, 2004, Novint recognized this amount as reduction of the offering proceeds. In May 2004, Novint issued 250,000 warrants to a consultant for services to be rendered in connection with its marketing strategy. The warrants will have an exercise price of $1.00 per share and will vest at a rate of 10,000 shares for each $1,000,000 in contract revenue associated with the consultant's efforts. As no associated revenue had been recorded for the 9 months ended September 30, 2004, no impact is reflected on the accompanying financial statements. During the 9 months ended September 30, 2004, Novint committed to issue 304,900 warrants in connection with an over allotment agreement with a consulting group for private placement services. The warrants will have an exercise price of $1.00 per share and will have a six-month term. The date of issue will be coincident with the date of Novint's initial public offering. As Novint is currently undergoing initial public offering procedures and does not know of their initial public offering date, these warrants are not outstanding as of September 30, 2004. 17 Novint Technologies, Inc. NOTES TO UNAUDITED FINANCIAL STATEMENTS September 30, 2004 NOTE 12 - RELATED PARTIES In April 2000, Sandia licensed to Novint the right to utilize the Flight technology, which is the precursor to e-TouchTM, exclusively for a period of 12 years and non-exclusively in perpetuity, as well as requiring Novint to pay 1.5 percent royalty fees to Sandia in connection with any income earned based upon the technology. In connection with this licensing agreement, Novint issued 4,000 shares of Series A mandatorily redeemable, convertible preferred stock, which can be converted into 447,300 shares of common stock. The preferred stock is convertible into fully paid and nonassessable common stock as follows: at the holder's option based on the conversion price in effect on the conversion date, or automatically upon the closing of an initial public offering. The conversion price is to be (i) the subscription price ($100,000 when expressed as an aggregate amount, or $25 per share when expressed on a per share basis) divided by (ii) the conversion price in effect on the conversion date. Additionally, during November 2002, Novint issued to Sandia 40,000 shares of common stock as repayment of their 2001 and 2002 royalty fees, which totaled $20,000, at $0.50 per share. As of December 31, 2003, Novint had a loan outstanding for $100,000 from an investor. This loan was repaid in March 2004. Manhattan Scientifics ("Manhattan") is Novint's main investor with approximately 30% and 41% ownership in Novint as of September 30, 2004 and December 31, 2003, respectively. During the nine months ended September 30, 2004, Manhattan provided consulting services to Novint in relation to their long-term strategic planning. As of September 30, 2004, Novint had paid $40,000 for these services. On February 25, 2004, Novint issued 10,000 shares of common stock at $1.00 per share to a former Board of Director for consulting services performed. Novint recognized $10,000 in consulting expense based on the fair market value of the shares, when these shares were issued. In March 2004, Normandie New Mexico Corporation, which is owned by Manhattan's Chief Executive Officer (CEO), who is also a member of Novint's Board of Directors, entered into an agreement with Novint to provide consulting services in relation to business development and marketing support. Fees per the agreement are $6,250 per month. For the nine months ended September 30, 2004, Novint had paid $43,750 for these services. On April 1, 2004, Novint committed to issue 250,000 shares of common stock at $1.00 per share to Manhattan's Chief Operating Officer (COO) for future consulting services. Vesting terms are as follows: 50,000 shares per quarter as long as the COO is still providing services to Novint, up to a total of 250,000 shares, beginning April 1, 2004. Novint recognized $100,000 in consulting expense related to this issuance during the nine months ended September 30, 2004. On June 10, 2004, Novint granted 250,000 options to purchase common stock to Manhattan's CEO for future consulting services at an exercise price of $0.66 per share. The options have a 5-year annual vesting provision. Novint calculated the value of these options using the Black-Scholes model based on the following assumptions: a risk-free rate of 4.81%, volatility of 100%, estimated life of 10 years, and a fair market value of $1.00 per share. The vesting schedule is prorated over the reporting period, and approximately $13,000 was recorded as consultant expense during the nine months ended September 30, 2004. 18 Novint Technologies, Inc. NOTES TO UNAUDITED FINANCIAL STATEMENTS September 30, 2004 On June 10, 2004, Novint granted 25,000 options to purchase common stock to a former member of the Board of Directors for consulting services at an exercise price of $0.66 per share. These options immediately vest. Novint calculated the value of these options using the Black-Scholes model based on the following assumptions: a risk-free rate of 4.81%, volatility of 100%, estimated life of 10 years, and a fair market value of $1.00 per share. Approximately $23,000 was recorded as consultant expense during the 9 months ended September 30, 2004. During the quarters ended September 30, 2004 and 2003, Novint developed professional applications for Sandia. Novint recognized approximately $81,000 and $154,000 in revenues from Sandia during the nine months ended September 30, 2004 and 2003. 19 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Dated: December 29, 2004 NOVINT TECHNOLOGIES, INC. By: /s/ Tom Anderson ----------------------------------- Tom Anderson Its: Chief Executive Officer and Acting Chief Financial Officer 20